Overall, our findings suggest that some dietary factors present in the Mediterranean diet might protect from cutaneous melanoma.

No abstract

No abstract

Both TNF-alpha antagonists proved successful for the treatment of refractory, adult-onset PRP, yielding complete and persistent clinical responses in type-I PRP. Infliximab was associated with a more rapid onset of action, while treatment duration was comparable with etanercept. PRP type II warranted long-term therapy and showed relapse after drug discontinuation.